Sage Mountain Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $860K | Buy |
7,757
+1,022
| +15% | +$113K | 0.06% | 165 |
|
|
2025
Q1 | $755K | Buy |
6,735
+623
| +10% | +$69.8K | 0.06% | 157 |
|
|
2024
Q4 | $565K | Buy |
6,112
+1,023
| +20% | +$94.5K | 0.04% | 189 |
|
|
2024
Q3 | $427K | Buy |
5,089
+1,195
| +31% | +$100K | 0.04% | 228 |
|
|
2024
Q2 | $267K | Buy |
3,894
+520
| +15% | +$35.7K | 0.02% | 280 |
|
|
2024
Q1 | $247K | Sell |
3,374
-343
| -9% | -$25.1K | 0.03% | 283 |
|
|
2023
Q4 | $301K | Buy |
3,717
+345
| +10% | +$27.9K | 0.03% | 201 |
|
|
2023
Q3 | $253K | Buy |
3,372
+47
| +1% | +$3.52K | 0.03% | 208 |
|
|
2023
Q2 | $256K | Buy |
3,325
+80
| +2% | +$6.17K | 0.04% | 204 |
|
|
2023
Q1 | $269K | Buy |
+3,245
| New | +$269K | 0.04% | 182 |
|
|
2022
Q1 | – | Sell |
-5,062
| Closed | -$368K | – | 651 |
|
|
2021
Q4 | $368K | Buy |
5,062
+363
| +8% | +$26.4K | 0.04% | 388 |
|
|
2021
Q3 | $328K | Sell |
4,699
-31
| -0.7% | -$2.16K | 0.05% | 337 |
|
|
2021
Q2 | $326K | Buy |
+4,730
| New | +$326K | 0.05% | 302 |
|